URGENT UPDATE: In a shocking turn of events, 2025 PFL featherweight champion Movlid Khaybulaev has been suspended for one year after testing positive for a banned substance, the PFL announced just moments ago. This announcement comes on the heels of Khaybulaev’s victory over Jesus Pinedo via fifth-round submission on August 1, 2025, at Jim Whelan Boardwalk Hall in Atlantic City, N.J.
The positive test result, which revealed the presence of recombinant erythropoietin, was confirmed on the same day as his championship match. As a consequence, Khaybulaev’s suspension will be retroactive to the date of his positive test, stripping him of the title he fought hard to attain.
In an official statement, the PFL confirmed, “Pursuant to PFL rules and regulations, Khaybulaev has been disqualified from the 2025 PFL World Tournament. As a result of the disqualification under PFL rules, Khaybulaev forfeits the distinction of 2025 PFL featherweight tournament champion, the championship belt, and all associated bonus awards.”
This suspension comes at a critical time for the PFL, which has recently ended its partnership with the USADA. The drug test in question was conducted during the final days of this collaboration. The PFL is now working with the Mohegan Sun Tribe Department of Athletic Regulation to oversee its drug testing program moving forward.
The implications of this suspension are significant, not only for Khaybulaev but also for the integrity of the sport. Fans and athletes alike are reacting with disbelief as the featherweight division faces turmoil following this announcement. The champion’s legacy now hangs in the balance as the PFL reevaluates its policies and procedures regarding doping violations.
As the PFL navigates this developing situation, all eyes are on the organization to see how it will handle the fallout from this high-profile case. Will Khaybulaev appeal the suspension? What measures will the PFL implement to restore confidence in its competition?
Stay tuned for the latest updates as this story unfolds.
